The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents

JM Pantic, IP Jovanovic, GD Radosavljevic, NN Arsenijevic, JM Conlon, ML Lukic

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The aim of this article is to review the immunoregulatory actions of frog skin-derived peptides in order to assess their potential as candidates for immunomodulatory or anti-inflammatory therapy. Frog skin peptides with demonstrable immunomodulatory properties have been isolated from skin secretions of a range of species belonging to the families Alytidae, Ascaphidae, Discoglossidae,Leptodactylidae,PipidaeandRanidae. Theireffectsuponproductionofinflammatory and immunoregulatory cytokines by target cells have been evaluated ex vivo and effects upon cytokine expression and immune cell activity have been studied in vivo by flow cytometry after injectionintomice. Thenaturally-occurringpeptidesand/ortheirsyntheticanaloguesshowcomplex and variable actions on the production of proinflammatory (TNF-α, IL-1β, IL-12, IL-23, IL-8, IFN-γ and IL-17), pleiotropic (IL-4 and IL-6) and immunosuppressive (IL-10 and TGF-β) cytokines by peripheral and spleen cells, peritoneal cells and/or isolated macrophages. The effects of frenatin 2.1S include enhancement of the activation state and homing capacity of Th1-type lymphocytes and NK cells in the mouse peritoneal cavity, as well as the promotion of their tumoricidal capacities. Overall, the diverse effects of frog skin-derived peptides on the immune system indicate their potential for development into therapeutic agents.
LanguageEnglish
PagesE2071-E2071
JournalMolecules
Volume22
Issue number12
Early online date13 Dec 2017
DOIs
Publication statusE-pub ahead of print - 13 Dec 2017

Fingerprint

Anura
Skin
Peptides
Cytokines
Interleukin-23
Th1 Cells
Interleukin-17
Peritoneal Cavity
Interleukin-12
Immunosuppressive Agents
Interleukin-8
Natural Killer Cells
Interleukin-4
Transforming Growth Factor beta
Interleukin-10
Immune System
Interleukin-6
Flow Cytometry
Anti-Inflammatory Agents
Spleen

Keywords

  • frog skin peptides
  • host defence peptides
  • immunomodulatory
  • cytokine
  • antimicrobial

Cite this

Pantic, JM ; Jovanovic, IP ; Radosavljevic, GD ; Arsenijevic, NN ; Conlon, JM ; Lukic, ML. / The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents. In: Molecules. 2017 ; Vol. 22, No. 12. pp. E2071-E2071.
@article{852c746e7943445e9addf3a5e610a4fe,
title = "The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents",
abstract = "The aim of this article is to review the immunoregulatory actions of frog skin-derived peptides in order to assess their potential as candidates for immunomodulatory or anti-inflammatory therapy. Frog skin peptides with demonstrable immunomodulatory properties have been isolated from skin secretions of a range of species belonging to the families Alytidae, Ascaphidae, Discoglossidae,Leptodactylidae,PipidaeandRanidae. Theireffectsuponproductionofinflammatory and immunoregulatory cytokines by target cells have been evaluated ex vivo and effects upon cytokine expression and immune cell activity have been studied in vivo by flow cytometry after injectionintomice. Thenaturally-occurringpeptidesand/ortheirsyntheticanaloguesshowcomplex and variable actions on the production of proinflammatory (TNF-α, IL-1β, IL-12, IL-23, IL-8, IFN-γ and IL-17), pleiotropic (IL-4 and IL-6) and immunosuppressive (IL-10 and TGF-β) cytokines by peripheral and spleen cells, peritoneal cells and/or isolated macrophages. The effects of frenatin 2.1S include enhancement of the activation state and homing capacity of Th1-type lymphocytes and NK cells in the mouse peritoneal cavity, as well as the promotion of their tumoricidal capacities. Overall, the diverse effects of frog skin-derived peptides on the immune system indicate their potential for development into therapeutic agents.",
keywords = "frog skin peptides, host defence peptides, immunomodulatory, cytokine, antimicrobial",
author = "JM Pantic and IP Jovanovic and GD Radosavljevic and NN Arsenijevic and JM Conlon and ML Lukic",
year = "2017",
month = "12",
day = "13",
doi = "10.3390/molecules22122071",
language = "English",
volume = "22",
pages = "E2071--E2071",
journal = "Molecules",
issn = "1420-3049",
publisher = "MDPI",
number = "12",

}

Pantic, JM, Jovanovic, IP, Radosavljevic, GD, Arsenijevic, NN, Conlon, JM & Lukic, ML 2017, 'The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents', Molecules, vol. 22, no. 12, pp. E2071-E2071. https://doi.org/10.3390/molecules22122071

The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents. / Pantic, JM; Jovanovic, IP; Radosavljevic, GD; Arsenijevic, NN; Conlon, JM; Lukic, ML.

In: Molecules, Vol. 22, No. 12, 13.12.2017, p. E2071-E2071.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents

AU - Pantic, JM

AU - Jovanovic, IP

AU - Radosavljevic, GD

AU - Arsenijevic, NN

AU - Conlon, JM

AU - Lukic, ML

PY - 2017/12/13

Y1 - 2017/12/13

N2 - The aim of this article is to review the immunoregulatory actions of frog skin-derived peptides in order to assess their potential as candidates for immunomodulatory or anti-inflammatory therapy. Frog skin peptides with demonstrable immunomodulatory properties have been isolated from skin secretions of a range of species belonging to the families Alytidae, Ascaphidae, Discoglossidae,Leptodactylidae,PipidaeandRanidae. Theireffectsuponproductionofinflammatory and immunoregulatory cytokines by target cells have been evaluated ex vivo and effects upon cytokine expression and immune cell activity have been studied in vivo by flow cytometry after injectionintomice. Thenaturally-occurringpeptidesand/ortheirsyntheticanaloguesshowcomplex and variable actions on the production of proinflammatory (TNF-α, IL-1β, IL-12, IL-23, IL-8, IFN-γ and IL-17), pleiotropic (IL-4 and IL-6) and immunosuppressive (IL-10 and TGF-β) cytokines by peripheral and spleen cells, peritoneal cells and/or isolated macrophages. The effects of frenatin 2.1S include enhancement of the activation state and homing capacity of Th1-type lymphocytes and NK cells in the mouse peritoneal cavity, as well as the promotion of their tumoricidal capacities. Overall, the diverse effects of frog skin-derived peptides on the immune system indicate their potential for development into therapeutic agents.

AB - The aim of this article is to review the immunoregulatory actions of frog skin-derived peptides in order to assess their potential as candidates for immunomodulatory or anti-inflammatory therapy. Frog skin peptides with demonstrable immunomodulatory properties have been isolated from skin secretions of a range of species belonging to the families Alytidae, Ascaphidae, Discoglossidae,Leptodactylidae,PipidaeandRanidae. Theireffectsuponproductionofinflammatory and immunoregulatory cytokines by target cells have been evaluated ex vivo and effects upon cytokine expression and immune cell activity have been studied in vivo by flow cytometry after injectionintomice. Thenaturally-occurringpeptidesand/ortheirsyntheticanaloguesshowcomplex and variable actions on the production of proinflammatory (TNF-α, IL-1β, IL-12, IL-23, IL-8, IFN-γ and IL-17), pleiotropic (IL-4 and IL-6) and immunosuppressive (IL-10 and TGF-β) cytokines by peripheral and spleen cells, peritoneal cells and/or isolated macrophages. The effects of frenatin 2.1S include enhancement of the activation state and homing capacity of Th1-type lymphocytes and NK cells in the mouse peritoneal cavity, as well as the promotion of their tumoricidal capacities. Overall, the diverse effects of frog skin-derived peptides on the immune system indicate their potential for development into therapeutic agents.

KW - frog skin peptides

KW - host defence peptides

KW - immunomodulatory

KW - cytokine

KW - antimicrobial

U2 - 10.3390/molecules22122071

DO - 10.3390/molecules22122071

M3 - Article

VL - 22

SP - E2071-E2071

JO - Molecules

T2 - Molecules

JF - Molecules

SN - 1420-3049

IS - 12

ER -